MALVERN, Pa. & STAFFORD, England--(BUSINESS WIRE)--PuriCore (LSE:PURI), the life sciences company focused on the control of infectious pathogens with its patented, safe, and natural antimicrobial technology, will feature its latest developments and clinical results for its proprietary Vashe Wound Therapy Solution at the Symposium on Advanced Wound Care this week in San Diego, California. PuriCore’s technology mimics the human body’s production of the natural antimicrobial hypochlorous acid. Hypochlorous acid is highly effective against a broad range of microorganisms including MRSA, VRE, and numerous other bacteria, viruses, and fungal spores.
